OPRK1 and neoplasm: Critically, the analyses herein have identified OPRK1 as a potential novel therapeutic target; notably, OPRK1 expression was upregulated upon castration, and its loss of function retarded acquisition of CR progression by blocking cell proliferation and tumor growth in multiple CRPC models.